Amarin reported $0 in Debt for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Debt Change
Acceleron Pharma XLRN:US $ 0M 0M
Adamas Pharmaceuticals ADMS:US 129.04M 671K
Aerie Pharmaceuticals AERI:US $ 228.19M 6.17M
Alnylam Pharmaceuticals ALNY:US $ 433.8M 0.65M
Amarin AMRN:US $ 0M 0M
Arena Pharmaceuticals ARNA:US $ 42.37M 1.13M
AstraZeneca AZN:LN 31912M 4417M
Biocryst Pharmaceuticals BCRX:US $ 304.16M 10.51M
Epizyme EPZM:US $ 231.84M 0.64M
Esperion Therapeutics ESPR:US $ 272.51M 410K
GlaxoSmithKline GSK:LN 25605M 122M
Halozyme Therapeutics HALO:US $ 875.7M 0.97M
Heron Therapeutics HRTX:US $ 149.03M 0.05M
Intercept Pharmaceuticals ICPT:US $ 530.4M 45.42M
IONIS PHARMACEUT IONS:US $ 1303M 7.54M
JAZZ PHA JAZZ:US $ 6285.05M 459.25M
Nektar Therapeutics NKTR:US $ 0M 0M
Neurocrine Biosciences NBIX:US $ 330.7M 4.4M
Novartis NOVN:VX SF 34243M 1526M
Teva Pharmaceutical Industries TEVA:US $ 23746M 1386M